Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuaki Takeji

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
JACC. Asia|November 7, 2022
Stent-Related Adverse Events as Related to Dual Antiplatelet Therapy in First- vs Second-Generation Drug-Eluting StentsYusuke Yoshikawa, Hiroki Shiomi, Takeshi Morimoto, et al.
JACC. Cardiovascular Interventions|April 6, 2019
7-Year Outcomes of a Randomized Trial Comparing the First-Generation Sirolimus-Eluting Stent Versus the New-Generation Everolimus-Eluting Stent: The RESET TrialHiroki Shiomi, Ken Kozuma, Takeshi Morimoto, et al.
The American Journal of Cardiology|July 30, 2023
The Impact of Mitral Regurgitation on Long-Term Outcomes in Acute Myocardial Infarction Undergoing Percutaneous Coronary InterventionYuki Obayashi, Hiroki Shiomi, Takeshi Morimoto, et al.
The American Journal of Cardiology|August 16, 2022
Stroke Risk Stratification With the CHADS<sub>2</sub> Score in Patients Without Atrial Fibrillation Who Underwent Percutaneous Coronary InterventionYuki Obayashi, Hiroki Shiomi, Takeshi Morimoto, et al.
The American Journal of Cardiology|December 6, 2020
Periprocedural Stroke After Coronary Revascularization (from the CREDO-Kyoto PCI/CABG Registry Cohort-3)Ko Yamamoto, Masahiro Natsuaki, Takeshi Morimoto, et al.
The American Journal of Cardiology|January 17, 2021
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Versus Without Chronic Kidney DiseaseKo Yamamoto, Masahiro Natsuaki, Takeshi Morimoto, et al.
Plos One|November 17, 2021
Differences in mortality and causes of death between STEMI and NSTEMI in the early and late phases after acute myocardial infarctionYasuaki Takeji, Hiroki Shiomi, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 28, 2021
Effects of Acute Coronary Syndrome and Stable Coronary Artery Disease on Bleeding and Ischemic Risk After Percutaneous Coronary InterventionMasahiro Natsuaki, Takeshi Morimoto, Hiroki Shiomi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 18, 2023
Polypharmacy and Bleeding Outcomes After Percutaneous Coronary InterventionKo Yamamoto, Takeshi Morimoto, Masahiro Natsuaki, et al.
BMJ Open|February 23, 2021
Demographics, practice patterns and long-term outcomes of patients with non-ST-segment elevation acute coronary syndrome in the past two decades: the CREDO-Kyoto Cohort-2 and Cohort-3Yasuaki Takeji, Hiroki Shiomi, Takeshi Morimoto, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
JACC. Asia|November 7, 2022
Stent-Related Adverse Events as Related to Dual Antiplatelet Therapy in First- vs Second-Generation Drug-Eluting StentsYusuke Yoshikawa, Hiroki Shiomi, Takeshi Morimoto, et al.
JACC. Cardiovascular Interventions|April 6, 2019
7-Year Outcomes of a Randomized Trial Comparing the First-Generation Sirolimus-Eluting Stent Versus the New-Generation Everolimus-Eluting Stent: The RESET TrialHiroki Shiomi, Ken Kozuma, Takeshi Morimoto, et al.
The American Journal of Cardiology|July 30, 2023
The Impact of Mitral Regurgitation on Long-Term Outcomes in Acute Myocardial Infarction Undergoing Percutaneous Coronary InterventionYuki Obayashi, Hiroki Shiomi, Takeshi Morimoto, et al.
The American Journal of Cardiology|August 16, 2022
Stroke Risk Stratification With the CHADS<sub>2</sub> Score in Patients Without Atrial Fibrillation Who Underwent Percutaneous Coronary InterventionYuki Obayashi, Hiroki Shiomi, Takeshi Morimoto, et al.
The American Journal of Cardiology|December 6, 2020
Periprocedural Stroke After Coronary Revascularization (from the CREDO-Kyoto PCI/CABG Registry Cohort-3)Ko Yamamoto, Masahiro Natsuaki, Takeshi Morimoto, et al.
The American Journal of Cardiology|January 17, 2021
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Versus Without Chronic Kidney DiseaseKo Yamamoto, Masahiro Natsuaki, Takeshi Morimoto, et al.
Plos One|November 17, 2021
Differences in mortality and causes of death between STEMI and NSTEMI in the early and late phases after acute myocardial infarctionYasuaki Takeji, Hiroki Shiomi, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 28, 2021
Effects of Acute Coronary Syndrome and Stable Coronary Artery Disease on Bleeding and Ischemic Risk After Percutaneous Coronary InterventionMasahiro Natsuaki, Takeshi Morimoto, Hiroki Shiomi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 18, 2023
Polypharmacy and Bleeding Outcomes After Percutaneous Coronary InterventionKo Yamamoto, Takeshi Morimoto, Masahiro Natsuaki, et al.
BMJ Open|February 23, 2021
Demographics, practice patterns and long-term outcomes of patients with non-ST-segment elevation acute coronary syndrome in the past two decades: the CREDO-Kyoto Cohort-2 and Cohort-3Yasuaki Takeji, Hiroki Shiomi, Takeshi Morimoto, et al.
Pageof 7